BBH vs. PSCH
BBH (VanEck Vectors Biotech ETF) and PSCH (Invesco S&P SmallCap Health Care ETF) are both Health & Biotech Equities funds - BBH tracks the MVIS US Listed Biotech 25 Index while PSCH tracks the S&P SmallCap 600 Health Care Index. Both are passively managed. Over the past 10 years, BBH returned 5.75%/yr vs 6.81%/yr for PSCH. A 0.69 correlation means they provide meaningful diversification when combined. BBH charges 0.35%/yr vs 0.29%/yr for PSCH.
Performance
BBH vs. PSCH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBH achieves a -1.85% return, which is significantly lower than PSCH's 1.80% return. Over the past 10 years, BBH has underperformed PSCH with an annualized return of 5.75%, while PSCH has yielded a comparatively higher 6.81% annualized return.
BBH
- 1D
- 2.22%
- 1M
- 0.09%
- YTD
- -1.85%
- 6M
- -5.32%
- 1Y
- 23.92%
- 3Y*
- 6.14%
- 5Y*
- 0.31%
- 10Y*
- 5.75%
PSCH
- 1D
- 1.28%
- 1M
- -0.71%
- YTD
- 1.80%
- 6M
- -1.68%
- 1Y
- 10.18%
- 3Y*
- 0.45%
- 5Y*
- -5.72%
- 10Y*
- 6.81%
BBH vs. PSCH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | -1.85% | 21.18% | -4.29% | 3.94% | -15.25% | 11.81% | 22.13% | 26.34% | -10.70% | 16.46% |
PSCH Invesco S&P SmallCap Health Care ETF | 1.80% | -0.49% | 3.77% | -2.71% | -25.15% | 5.75% | 31.47% | 20.17% | 9.15% | 34.87% |
Correlation
The correlation between BBH and PSCH is 0.66, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.66 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.68 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.70 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.68 |
Correlation (All Time) Calculated using the full available price history since Apr 8, 2010 | 0.69 |
The correlation between BBH and PSCH has been stable across timeframes, ranging from 0.66 to 0.70 - a consistent structural relationship.
BBH vs. PSCH - Sectors Allocation Comparison
Sectors
BBH
PSCH
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
BBH
PSCH
Basic Materials
BBH
-
PSCH
-
Communication Services
BBH
-
PSCH
-
Consumer Cyclical
BBH
-
PSCH
-
Consumer Defensive
BBH
-
PSCH
-
Energy
BBH
-
PSCH
-
Financial Services
BBH
-
PSCH
Industrials
BBH
-
PSCH
Real Estate
BBH
-
PSCH
-
Technology
BBH
-
PSCH
Utilities
BBH
-
PSCH
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBH vs. PSCH — Risk / Return Rank
BBH
PSCH
BBH vs. PSCH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and Invesco S&P SmallCap Health Care ETF (PSCH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBH | PSCH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.76 | ||
| Sortino ratioReturn per unit of downside risk | +1.02 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.10 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 2.28 | 0.67 | +1.61 |
| Martin ratioReturn relative to average drawdown | 5.81 | 1.84 | +3.97 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBH | PSCH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.26 | 0.51 | +0.76 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.01 | -0.25 | +0.27 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.26 | 0.29 | -0.03 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.51 | -0.13 |
Drawdowns
BBH vs. PSCH - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.70%, which is greater than PSCH's maximum drawdown of -46.32%. Use the drawdown chart below to compare losses from any high point for BBH and PSCH.
Loading charts...
Drawdown Indicators
| BBH | PSCH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.70% | -46.32% | -26.38% |
Max Drawdown (1Y)Largest decline over 1 year | -10.55% | -15.36% | +4.81% |
Max Drawdown (3Y)Largest decline over 3 years | -22.74% | -22.98% | +0.24% |
Max Drawdown (5Y)Largest decline over 5 years | -39.86% | -46.32% | +6.46% |
Max Drawdown (10Y)Largest decline over 10 years | -39.86% | -46.32% | +6.46% |
Current DrawdownCurrent decline from peak | -13.81% | -30.59% | +16.78% |
Average DrawdownAverage peak-to-trough decline | -20.75% | -13.46% | -7.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.13% | 5.54% | -1.41% |
Volatility
BBH vs. PSCH - Volatility Comparison
VanEck Vectors Biotech ETF (BBH) has a higher volatility of 6.06% compared to Invesco S&P SmallCap Health Care ETF (PSCH) at 4.19%. This indicates that BBH's price experiences larger fluctuations and is considered to be riskier than PSCH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBH | PSCH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.06% | 4.19% | +1.87% |
Volatility (6M)Calculated over the trailing 6-month period | 14.28% | 14.06% | +0.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.02% | 20.26% | -1.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.50% | 22.89% | -1.39% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.17% | 23.63% | -1.46% |
BBH vs. PSCH - Expense Ratio Comparison
BBH has a 0.35% expense ratio, which is higher than PSCH's 0.29% expense ratio.
Dividends
BBH vs. PSCH - Dividend Comparison
BBH's dividend yield for the trailing twelve months is around 0.51%, more than PSCH's 0.01% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.51% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
PSCH Invesco S&P SmallCap Health Care ETF | 0.01% | 0.04% | 0.27% | 0.01% | 2.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% |
Frequently Asked Questions
BBH and PSCH have a correlation of 0.66, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBH has higher volatility (6.06%) compared to PSCH (4.19%). In terms of maximum drawdown, BBH dropped -72.70% vs PSCH's -46.32%.
On 10-year performance, PSCH leads with 6.81% vs 5.75% for BBH. On fees, PSCH is cheaper at 0.29% per year. On volatility, PSCH has been the lower-risk option at 4.19%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, PSCH has performed better with a 6.81% return vs 5.75%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PSCH is cheaper with a 0.29% expense ratio, compared with 0.35% for BBH.
BBH has the higher dividend yield at 0.51%, compared with 0.01% for PSCH.
BBH tracks MVIS US Listed Biotech 25 Index, while PSCH tracks S&P SmallCap 600 Health Care Index. They also come from different issuers: VanEck and Invesco. Their fees differ too: 0.35% for BBH and 0.29% for PSCH.
BBH currently has the higher Sharpe Ratio (1.26 vs 0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBH and PSCH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer